Alcon annual asset turnover
2009
2010
2018
2019
2020
2021
2022
2023
2024
2025
Alcon Asset Turnover Growth & History (ALC)
Alcon's asset turnover was 0.34 for fiscal 2025.
View full Alcon company overviewAlcon annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.34 | 0.01 | +1.65% |
| 2024 | 2024-12-31 | 0.33 | 0.01 | +2.76% |
| 2023 | 2023-12-31 | 0.32 | 0.02 | +5.49% |
| 2022 | 2022-12-31 | 0.30 | 0.01 | +2.26% |
| 2021 | 2021-12-31 | 0.30 | 0.05 | +20.59% |
| 2020 | 2020-12-31 | 0.25 | −0.03 | −9.88% |
| 2019 | 2019-12-31 | 0.27 | −0.11 | −28.76% |
| 2018 | 2018-12-31 | 0.39 | — | — |
| 2010 | 2010-12-31 | 0.77 | −0.04 | −4.39% |
| 2009 | 2009-12-31 | 0.80 | — | — |
Alcon quarterly asset turnover
Q1.10
Q2.10
Q3.10
Q4.10
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.35 | — | — |
| Q1 2026 | 2026-03-31 | 0.34 | — | — |
| Q4 2025 | 2025-12-31 | 0.34 | — | — |
| Q4 2010 | 2010-12-31 | 0.77 | — | — |
| Q3 2010 | 2010-09-30 | 0.80 | — | — |
| Q2 2010 | 2010-06-30 | 0.86 | — | — |
| Q1 2010 | 2010-03-31 | 0.80 | — | — |
Alcon asset turnover trends
Over the last five fiscal years, Alcon's asset turnover increased from 0.25 to 0.34, a change of 0.09. The latest reported quarter, Q2 2026, shows 0.35.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alcon source filings ↗Community posts
Alcon completes $550 million Neurotech acquisition to enter MacTel treatment
Alcon ($ALC) has acquired Neurotech for $550 million, with additional payments dependent on commercial milestones. The transaction adds ENCELTO, a cell-based ocular therapy for adults with macular telangiectasia type 2. The product received ...
